AFT expects $5mln cash from selling hospital products range to Baxter Healthcare

Sophie Boot
Tue, 20 Mar 2018

By Sophie Boot March 21 (BusinessDesk) - AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, is selling its "non-core hospital products" to Fortune 500 company Baxter Healthcare in New Zealand and expects to do the same in Australia. Baxter, which is listed on the New York Stock Exchange, bought Claris, who AFT had an agreement with, in 2017. Claris's website describes the company as a skin specialist and provides mole mapping and surgical treatments such as biopsies and mole removal. AFT said its deal with Claris in New Zea...
Opinion
ON THE MONEY: Boag, BNZ, Crimson and more
Victoria Young | Sat, 11 Jul 2020

Professional distancing We’re sure public relations expert and National Party stalwart Michelle Boag has had a few ups and downs in her colourful career, but you know things are rough when one of your...

Opinion
JEHAN CASINADER: Politicians are the worst advertisement for democracy
Jehan Casinader | Sat, 11 Jul 2020

In Wellington, when it rains, it pours.In recent weeks, there has been a steady stream of political scandals. Blunders, sagas, hiccups and missteps – too many to count.These events remind us why so ma...

Economy
BRIAN GAYNOR: Aluminium smelter reaches use by date
Brian Gaynor | Sat, 11 Jul 2020

The negative market reaction to Rio Tinto’s announcement that it was winding down the Tiwai Point aluminium smelter was overdone, particularly for investors with long-term perspectives. The smelter...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.

Sponsored: What’s next for the future of the office?

Think everyone is going to keep working from home? No so fast, says Milford Asset Management.